Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$592K Sell
4,923
-384
-7% -$44.3K 0.12% 121
2025
Q4
$559K Sell
5,307
-160
-3% -$15K 0.11% 121
2025
Q3
$459K Sell
5,467
-2,187
-29% -$180K 0.1% 127
2025
Q2
$606K Sell
7,654
-362
-5% -$28.8K 0.15% 106
2025
Q1
$720K Sell
8,016
-162
-2% -$15.1K 0.2% 84
2024
Q4
$814K Buy
8,178
+1,943
+31% +$200K 0.24% 77
2024
Q3
$708K Sell
6,235
-112
-2% -$13.3K 0.22% 75
2024
Q2
$786K Buy
6,347
+1,133
+22% +$146K 0.28% 64
2024
Q1
$688K Sell
5,214
-7
-0.1% -$863 0.27% 68
2023
Q4
$569K Buy
5,221
+109
+2% +$11.3K 0.25% 74
2023
Q3
$526K Sell
5,112
-656
-11% -$70.7K 0.26% 71
2023
Q2
$666K Buy
5,768
+3,387
+142% +$385K 0.34% 54
2023
Q1
$253K Buy
+2,381
New +$257K 0.17% 110

Other funds holding MRK

ABLE Financial Group's MRK Position: Q1 2026 in Review

ABLE Financial Group reduced its Merck (MRK) stake by 7.2% in Q1 2026, selling an estimated $44.3K and leaving 4,923 shares worth $592K. The position accounts for 0.12% of the portfolio, ranked #121.

ABLE Financial Group first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $814K in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • ABLE Financial Group held 4,923 shares of Merck worth $592K as of Q1 2026.
  • ABLE Financial Group sold 384 Merck shares in Q1 2026, an estimated $44.3K.
  • Merck made up 0.12% of ABLE Financial Group's portfolio in Q1 2026, its #121 holding.
  • ABLE Financial Group first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • ABLE Financial Group's Merck position peaked at $814K in Q4 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on ABLE Financial Group's 13F filing for Q1 2026, filed 21 Apr 2026.